Study on CD44 as a Cancer Stem Cell Marker for Head and Neck Squamous Cell Carcinoma
CD44, a hyaluronic acid cell-surface glycoprotein receptor, has been linked to tumour growth and progression, as well as being used as a Cancer Stem Cell (CSC) marker in head and neck squamous cell carcinoma (HNSCC). CD44's prognostic usefulness, on the
Read More